ClinConnect ClinConnect Logo
Search / Trial NCT05900778

Implementation of a HABIT-ILE Intervention at William Lennox Neurological Hospital (NeuREHA)

Launched by UNIVERSITÉ CATHOLIQUE DE LOUVAIN · Jun 2, 2023

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

Motor Skill Learning Executive Function Activity Of Daily Living Intensive Therapy Acquired Brain Injury

ClinConnect Summary

This clinical trial, called the NeuREHA study, is investigating a treatment program known as "Hand-arm Bimanual Intensive Therapy Including Lower Extremities" (HABIT-ILE) for children who have suffered an acquired brain injury. The goal is to see how this therapy can help improve daily activities, movement skills, and thinking abilities in children aged 5 to 18 years. The trial is currently looking for participants who meet specific criteria, such as being of school age and having an acquired brain injury, while those with certain medical conditions or recent surgeries are not eligible.

If your child is eligible and chooses to participate, they will engage in the HABIT-ILE therapy in a hospital setting, where their progress will be monitored. This study aims to provide valuable insights into how this treatment can support children in their daily lives after a brain injury. The research team is committed to ensuring a supportive environment, and participants will have the opportunity to contribute to important findings that may benefit future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • children with acquired brain injury of school
  • age 5 to 18 years inclusive
  • Exclusion Criteria:
  • Unstable seizure
  • programmed botulinum toxin or orthopedic surgery in the 6 months previous to the intervention, during intervention period or 3months after the intervention time
  • Severe visual or cognitive impairments likely to interfere with intervention or testing session completion

About Université Catholique De Louvain

Université Catholique de Louvain (UCLouvain) is a prestigious Belgian institution renowned for its commitment to academic excellence, research innovation, and interdisciplinary collaboration. With a strong emphasis on advancing medical science and improving patient outcomes, UCLouvain conducts a range of clinical trials across various medical fields. The university's research initiatives are supported by cutting-edge facilities and a team of experienced professionals, fostering a robust environment for clinical investigation. UCLouvain is dedicated to ethical research practices and aims to contribute significantly to the global body of medical knowledge through its clinical trial endeavors.

Locations

Brussels, , Belgium

Ottignies Louvain La Neuve, Brabant Wallon, Belgium

Bruxelles, , Belgium

Patients applied

0 patients applied

Trial Officials

Yannick Bleyenheuft, Professor

Principal Investigator

Insititue of Neurosciences, UCLouvain

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported